Typhoid vaccine: A case for inclusion in national program
Typhoid has been reported to be a common and significant cause of morbidity in pre-school and school-age children in the endemic countries like India. The incidence of typhoid has been reported to be as high as 27.3 per 1000 person-years in children less than 5 years of age. Serious complications oc...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | Indian Journal of Public Health |
Subjects: | |
Online Access: | http://www.ijph.in/article.asp?issn=0019-557X;year=2011;volume=55;issue=4;spage=267;epage=271;aulast=Sharma |
id |
doaj-ba52ae95ad604b588bc4c633c16adbfa |
---|---|
record_format |
Article |
spelling |
doaj-ba52ae95ad604b588bc4c633c16adbfa2020-11-25T00:09:37ZengWolters Kluwer Medknow PublicationsIndian Journal of Public Health0019-557X2011-01-0155426727110.4103/0019-557X.92403Typhoid vaccine: A case for inclusion in national programPragya SharmaDavendra K TanejaTyphoid has been reported to be a common and significant cause of morbidity in pre-school and school-age children in the endemic countries like India. The incidence of typhoid has been reported to be as high as 27.3 per 1000 person-years in children less than 5 years of age. Serious complications occur in about 10% of cases requiring hospitalization. The mean cost of treatment per episode of blood culture-confirmed typhoid fever has been calculated as INR 3,597 (1996 prices) in an outdoor setting, whereas in case of hospitalization, the cost of illness increases by several folds (INR 18,131). Vi polysaccharide vaccine is safe, efficacious and affordable for use as a cost-effective public health tool to protect children from typhoid and related complications, when given at 2 and 5 years of age as a part of National Immunization Schedule.http://www.ijph.in/article.asp?issn=0019-557X;year=2011;volume=55;issue=4;spage=267;epage=271;aulast=SharmaBurdenPreventionTyphoidVaccine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pragya Sharma Davendra K Taneja |
spellingShingle |
Pragya Sharma Davendra K Taneja Typhoid vaccine: A case for inclusion in national program Indian Journal of Public Health Burden Prevention Typhoid Vaccine |
author_facet |
Pragya Sharma Davendra K Taneja |
author_sort |
Pragya Sharma |
title |
Typhoid vaccine: A case for inclusion in national program |
title_short |
Typhoid vaccine: A case for inclusion in national program |
title_full |
Typhoid vaccine: A case for inclusion in national program |
title_fullStr |
Typhoid vaccine: A case for inclusion in national program |
title_full_unstemmed |
Typhoid vaccine: A case for inclusion in national program |
title_sort |
typhoid vaccine: a case for inclusion in national program |
publisher |
Wolters Kluwer Medknow Publications |
series |
Indian Journal of Public Health |
issn |
0019-557X |
publishDate |
2011-01-01 |
description |
Typhoid has been reported to be a common and significant cause of morbidity in pre-school and school-age children in the endemic countries like India. The incidence of typhoid has been reported to be as high as 27.3 per 1000 person-years in children less than 5 years of age. Serious complications occur in about 10% of cases requiring hospitalization. The mean cost of treatment per episode of blood culture-confirmed typhoid fever has been calculated as INR 3,597 (1996 prices) in an outdoor setting, whereas in case of hospitalization, the cost of illness increases by several folds (INR 18,131). Vi polysaccharide vaccine is safe, efficacious and affordable for use as a cost-effective public health tool to protect children from typhoid and related complications, when given at 2 and 5 years of age as a part of National Immunization Schedule. |
topic |
Burden Prevention Typhoid Vaccine |
url |
http://www.ijph.in/article.asp?issn=0019-557X;year=2011;volume=55;issue=4;spage=267;epage=271;aulast=Sharma |
work_keys_str_mv |
AT pragyasharma typhoidvaccineacaseforinclusioninnationalprogram AT davendraktaneja typhoidvaccineacaseforinclusioninnationalprogram |
_version_ |
1725410767663005696 |